Adverse Effects of SARS-CoV-2 Vaccines in Kidney Transplant Recipients

SARS-CoV-2 疫苗对肾移植受者的不良影响

• 批准号: 459232
• 负责人: Sapir-Pichhadze Ruth
• 金额: $ 36.41万
• 依托单位: Research Institute of the McGill University Health Centre
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-09-01 至 2022-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=459232&lang=en
• 关键词: Covid-19; Ethnocultural And Indigenous Communities; Genomics; Hla; Immunogenetics; Immunosuppression; Kidney Transplantation; Sars-Cov-2; Sex; Survival

The COVID-19 pandemic has presented an unprecedented challenge to Canada. To date, >1.5 million Canadians have been infected with the SARS-CoV-2 virus, and >27,000 individuals have died. The impact is even greater in kidney transplant recipients (KTR), of

新冠肺炎疫情对加拿大提出了前所未有的挑战。迄今为止，已有150万加拿大人感染了SARS-CoV-2病毒，27,000人死亡。对肾移植受者(KTR)的影响甚至更大